RANK Ligand inhibitor

Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Street Insider
Mon, 05/17/10 - 10:36 am
Amgen
BLA
FDA
denosumab
RANK Ligand inhibitor